The global spinal implants market is forecasted to grow at a 7 percent compound annual growth rate to exceed $19.5 billion by 2024, according to a Market Research Engine report.
Spinal Tech
Here are 12 key notes from orthopedic and spine device companies in the past week.
Camille Farhat, president and CEO of RTI Surgical, discusses the key technology trends in spine today and where his company is headed in the future.
Medacta International appointed Francesco Siccardi as CEO, effective Nov. 1.
About a month after it's billion-dollar acquisition of K2M, Stryker continues to make smaller acquisitions to complement its product portfolio.
Advertisement
Interventional pain management physician Claudio Vincenty, MD, has focused his career around back pain management. He has a special interest in spinal cord stimulation and advanced implant therapies.
The FDA granted Zimmer Biomet's request to extend its Mobi-C Cervical Disc labeling to include seven-year clinical results.
On Sept. 28, the Securities and Exchange Commission charged Stryker with violating the books and records and internal accounting controls provisions for the Foreign Corrupt Practices Act.
The global thoracolumbar spine devices market is anticipated to grow at a 6.5 percent compound annual growth rate between 2017 and 2023, according to a Market Research Future report.
Camille Farhat is the president and CEO of RTI Surgical.